Skip to main content
Clinical Trials/NCT05201742
NCT05201742CompletedNot Applicable

A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism

King Saud University2 sites in 1 country18 target enrollmentStarted: February 6, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Locations
2
Primary Endpoint
Maximum inspiratory pressure (MIP)

Study Overview

Brief Summary

Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.

Detailed Description

The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to 75 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients diagnosed as having Parkinsonism Disease by the Neuro physician.
  • Duration of Parkinson's Disease ≥ 5 years.
  • Patients with the age of 65 to 80 years.
  • Hoen and Yahr classification within 1 to
  • Both males and females were included.
  • Patients who were able to comprehend the commands.
  • Patients who were willing to participate.

Exclusion Criteria

  • Patients having any cardiovascular and pulmonary disorders.
  • History of smoking currently or in the past.
  • Psychological Impairment.
  • Insufficient verbal/intellectual understanding.
  • Patients with unstable vital parameters.
  • Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.

Outcomes

Primary Outcomes

Maximum inspiratory pressure (MIP)

Time Frame: 6 weeks

Maximum inspiratory pressure was measured.

Forced vital capacity (FVC)

Time Frame: 6 weeks

Forced vital capacity was measured.

6-minute walk distance (6 MWD)

Time Frame: 6 weeks

Distance walked by the patients in 6 minutes was measured.

Forced expiratory volume in 1 second (FEV1)

Time Frame: 6 weeks

Forced expiratory volume in 1 second was measured

Peak Expiratory Flow Rate (PEFR)

Time Frame: 6 weeks

Peak Expiratory Flow Rate was measured

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Masood Khan

Researcher

King Saud University

Study Sites (2)

Loading locations...

Similar Trials